Acquisition of Nilotinib (Tasigna®) Capsules, or Equivalent

Inactive Total Small Business Set-Aside (FAR 19.5)
Notice ID:75N91023Q00019

The purpose of this amendment is to extend the submission deadline until January 6, 2023, 03:00 pm EST. This is a combined synopsis/solicitation for commercial items, prepared in accordance with the f...

Department/Ind.Agency Subtier Office
HEALTH AND HUMAN SERVICES, DEPARTMENT OF NATIONAL INSTITUTES OF HEALTH NIH NCI
  PSC   DRUGS AND BIOLOGICALS
LOCATION:

Links ()

Attachments ()


Data sourced from SAM.gov. View Official Posting »